Abstract
Introduction Primary effusion lymphoma (PEL) is a rare malignancy that accounts for 5% of HIV-related non-Hodgkin lymphoma (NHL). It usually presents as a lymphomatous growth in liquid phase within various body cavities such as the pleural, pericardial, and peritoneal spaces. Although extracavitary tumors can occur in PEL, they do so rarely but may be histologically indistinguishable from PEL. PEL s also defined by the expression of Kaposi sarcoma–associated heresvirus (KSHV) (also known as human herpesvirus 8 [HHV8]) in
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
